Quest Diagnostics Incorporated Cash Flow Conversion Efficiency
Quest Diagnostics Incorporated cash flow conversion efficiency. Based on the latest financial reports, Quest Diagnostics Incorporated (DGX) has a cash flow conversion efficiency ratio of 0.060x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($468.00 Million) by net assets ($7.82 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Quest Diagnostics Incorporated (1996–2025)
Cash flow conversion efficiency of Quest Diagnostics Incorporated from 1996 to 2025. This chart illustrates how Quest Diagnostics Incorporated's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Quest Diagnostics Incorporated stock quote for real-time trading data and today's change.
Quest Diagnostics Incorporated Cash Flow Conversion Ratio Explained
Quest Diagnostics Incorporated cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Quest Diagnostics Incorporated Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Quest Diagnostics Incorporated ranked by their cash flow conversion efficiency. Also see market value of Quest Diagnostics Incorporated for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
China Hongqiao Group Ltd
F:H0Q
|
N/A |
|
Hershey Co
NYSE:HSY
|
0.099x |
|
Ecopetrol S.A
F:ECHA
|
0.083x |
|
Kia Corp
KO:000270
|
0.070x |
|
InterContinental Hotels Group PLC
LSE:IHG
|
-0.215x |
|
Global Unichip Corp
TW:3443
|
0.258x |
|
CenterPoint Energy Inc
NYSE:CNP
|
0.066x |
|
Power Grid Corporation of India Limited
NSE:POWERGRID
|
0.148x |
Annual Cash Flow Conversion Efficiency for Quest Diagnostics Incorporated (1996–2025)
The table below shows the annual cash flow conversion efficiency of Quest Diagnostics Incorporated from 1996 to 2025. Review free cash flow generation of Quest Diagnostics Incorporated to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $7.29 Billion | $1.89 Billion | 0.259x | +33.81% |
| 2024-12-31 | $6.90 Billion | $1.33 Billion | 0.193x | -2.40% |
| 2023-12-31 | $6.42 Billion | $1.27 Billion | 0.198x | -30.70% |
| 2022-12-31 | $6.01 Billion | $1.72 Billion | 0.286x | -15.95% |
| 2021-12-31 | $6.56 Billion | $2.23 Billion | 0.340x | +16.96% |
| 2020-12-31 | $6.89 Billion | $2.00 Billion | 0.291x | +34.90% |
| 2019-12-31 | $5.76 Billion | $1.24 Billion | 0.216x | -3.95% |
| 2018-12-31 | $5.34 Billion | $1.20 Billion | 0.225x | -3.78% |
| 2017-12-31 | $5.04 Billion | $1.18 Billion | 0.233x | +3.41% |
| 2016-12-31 | $4.74 Billion | $1.07 Billion | 0.226x | +33.26% |
| 2015-12-31 | $4.78 Billion | $810.00 Million | 0.169x | -21.82% |
| 2014-12-31 | $4.33 Billion | $938.00 Million | 0.217x | +32.00% |
| 2013-12-31 | $3.97 Billion | $652.00 Million | 0.164x | -42.13% |
| 2012-12-31 | $4.19 Billion | $1.19 Billion | 0.284x | +17.65% |
| 2011-12-31 | $3.71 Billion | $895.50 Million | 0.241x | -12.59% |
| 2010-12-31 | $4.05 Billion | $1.12 Billion | 0.276x | +10.91% |
| 2009-12-31 | $4.01 Billion | $997.40 Million | 0.249x | -15.69% |
| 2008-12-31 | $3.60 Billion | $1.06 Billion | 0.295x | +5.76% |
| 2007-12-31 | $3.32 Billion | $926.92 Million | 0.279x | -11.56% |
| 2006-12-31 | $3.02 Billion | $951.90 Million | 0.315x | +2.29% |
| 2005-12-31 | $2.76 Billion | $851.58 Million | 0.308x | -11.69% |
| 2004-12-31 | $2.29 Billion | $798.78 Million | 0.349x | +26.10% |
| 2003-12-31 | $2.39 Billion | $662.80 Million | 0.277x | -17.91% |
| 2002-12-31 | $1.77 Billion | $596.37 Million | 0.337x | -3.30% |
| 2001-12-31 | $1.34 Billion | $465.80 Million | 0.349x | -2.63% |
| 2000-12-31 | $1.03 Billion | $369.45 Million | 0.358x | +23.87% |
| 1999-12-31 | $863.10 Million | $249.50 Million | 0.289x | +16.10% |
| 1998-12-31 | $567.90 Million | $141.40 Million | 0.249x | -23.50% |
| 1997-12-31 | $541.70 Million | $176.30 Million | 0.325x | +298.14% |
| 1996-12-31 | $538.72 Million | $-88.49 Million | -0.164x | -- |
About Quest Diagnostics Incorporated
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagn… Read more